Research Library

Browse, search, and filter the complete database of verified scientific literature

22 results for “harmine
Year:
Showing 22 of 185 articles

Filters

Year:
Clinical Trials
DOI Resolved

Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers

Aicher HD, Dornbierer J, Caflisch L et al.
Psychopharmacology, 2026
Randomized Controlled Trial
Depression & Mood
DOI Resolved

Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats

Lodetti G, de Bitencourt RM, Inserra A et al.
Progress in neuro-psychopharmacology & biological psychiatry, 2026
Longitudinal observational
Clinical Trials
DOI Resolved

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [18F]FDG-PET study

Egger K, Bozsak R, Aicher HD et al.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2026
Neuroimaging study
Clinical Trials
DOI Resolved

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review

Stojanović T, Nilsson KW, Fredriksson R et al.
Clinical pharmacology and therapeutics, 2026
Systematic review
Pharmacology
PubMed Verified

Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjects

Abelo A, Smallridge JW, Von Rotz R et al.
Biomedicine & Pharmacotherapy, 2025
Open Access
Pharmacokinetic modeling
Pharmacology
PubMed Verified

Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: a factorial dose-escalation study

Egger K, Jareno Redondo J, Mueller J et al.
Biomedicine & Pharmacotherapy, 2025
5 citationsOpen Access
Randomized controlled trial